BOSTON, June 15 Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has developed a relay lense adapter system for its MammoView® product line. The new system allows the MammoView® scope and endocoupler to join with virtually all video systems currently used in endoscopic procedures. Solos now has the flexibility to market the MammoView® to those customers that previously could not utilize their existing video systems with the MammoView® scope due to incompatibility issues surrounding inconsistent thread sizes between the video camera and endocoupler.
The Company previously developed a new endocoupler with an eye piece for the MammoView® system. Along with its current endocoupler and the eye piece endocoupler, the new adapters will allow the MammoView® scope to be used by the vast majority of the video systems currently in the market place.
"The new adapters allow us to offer the MammoView system to a wider customer base that was previously excluded due to both incompatibility issues with existing video systems as well as the prohibitive additional cost of purchasing a new video system," stated Bob Segersten, President of Solos Endoscopy, Inc.
Throughout the remainder of 2010, the Company will continue its new product development for the MammoView® product line as well as market expansion through its efforts to meet the requirements of the ISO 13485 standard and ultimately obtain the CE Mark and the permission to sell medical devices in the European Union and Canada.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.